TransMedics Group, Inc.TMDXNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank34
3Y CAGR-9.9%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-9.9%/yr
vs -17.3%/yr prior
Acceleration
+7.4pp
Accelerating
Percentile
P34
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 10.45% |
| Q3 2025 | -12.44% |
| Q2 2025 | 9.48% |
| Q1 2025 | 22.52% |
| Q4 2024 | 18.35% |
| Q3 2024 | -12.02% |
| Q2 2024 | 15.53% |
| Q1 2024 | 24.91% |
| Q4 2023 | 17.86% |
| Q3 2023 | 10.67% |
| Q2 2023 | 27.72% |
| Q1 2023 | 38.95% |
| Q4 2022 | 14.29% |
| Q3 2022 | 26.24% |
| Q2 2022 | 18.56% |
| Q1 2022 | 73.26% |
| Q4 2021 | 85.16% |
| Q3 2021 | -32.49% |
| Q2 2021 | 16.17% |
| Q1 2021 | -0.35% |
| Q4 2020 | -4.17% |
| Q3 2020 | 163.91% |
| Q2 2020 | -60.72% |
| Q1 2020 | 29.91% |
| Q4 2019 | -11.27% |
| Q3 2019 | 26.49% |
| Q2 2019 | 29.54% |
| Q1 2019 | 71.65% |
| Q4 2018 | -29.69% |
| Q3 2018 | 80.83% |
| Q2 2018 | 27.60% |
| Q1 2018 | 74.67% |
| Q4 2017 | 9.07% |
| Q3 2017 | -40.20% |
| Q3 2017 | 44.43% |
| Q2 2017 | 0.00% |